TrialTargeted oncology2015

Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: randomized non-comparative phase IIIb NEXT trial.

David F Heigener et al.PubMed ↗Publisher ↗

No numbers read from the abstract.